ILYANG PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 007570 for the last quarter is 82.70 B KRW, and it's 5.37% higher compared to the previous quarter. The net income of Q2 24 is 1.09 B KRW.